A total of 118 target regions for 13 genes (including ALK, ATM, BRCA1, BRCA2, EGFR, ERBB2, FGFR2, MET, NTRK1, NTRK2, NTRK3, PIK3CA, and ROS1) were evaluated for the target-level coverage distribution between tumor types among clinical samples. This evidence concerns the gene NTRK3 and neoplasm.